BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1032 related articles for article (PubMed ID: 15537442)

  • 1. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD;
    J Bone Miner Res; 2004 Dec; 19(12):1994-9. PubMed ID: 15537442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disc space narrowing as a new risk factor for vertebral fracture: the OFELY study.
    Sornay-Rendu E; Allard C; Munoz F; Duboeuf F; Delmas PD
    Arthritis Rheum; 2006 Apr; 54(4):1262-9. PubMed ID: 16572461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse relationship between vertebral fractures and spine osteoarthritis in postmenopausal women with osteoporosis.
    Roux C; Fechtenbaum J; Briot K; Cropet C; Liu-Léage S; Marcelli C
    Ann Rheum Dis; 2008 Feb; 67(2):224-8. PubMed ID: 17557888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of osteopenic women at high risk of fracture: the OFELY study.
    Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study.
    Sornay-Rendu E; Boutroy S; Munoz F; Delmas PD
    J Bone Miner Res; 2007 Mar; 22(3):425-33. PubMed ID: 17181395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between back pain and future vertebral fracture in postmenopausal women.
    Kuroda T; Shiraki M; Tanaka S; Shiraki Y; Narusawa K; Nakamura T
    Spine (Phila Pa 1976); 2009 Aug; 34(18):1984-9. PubMed ID: 19680106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
    Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD
    J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis.
    Chen P; Miller PD; Delmas PD; Misurski DA; Krege JH
    J Bone Miner Res; 2006 Nov; 21(11):1785-90. PubMed ID: 17002571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture prediction from bone mineral density in Japanese men and women.
    Fujiwara S; Kasagi F; Masunari N; Naito K; Suzuki G; Fukunaga M
    J Bone Miner Res; 2003 Aug; 18(8):1547-53. PubMed ID: 12929946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women.
    Antoniucci DM; Sellmeyer DE; Cauley JA; Ensrud KE; Schneider JL; Vesco KK; Cummings SR; Melton LJ;
    J Bone Miner Res; 2005 May; 20(5):741-7. PubMed ID: 15824846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between osteoporosis and cardiovascular disease in postmenopausal women.
    Tankó LB; Christiansen C; Cox DA; Geiger MJ; McNabb MA; Cummings SR
    J Bone Miner Res; 2005 Nov; 20(11):1912-20. PubMed ID: 16234963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
    Watts NB; Geusens P; Barton IP; Felsenberg D
    J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis.
    Sinigaglia L; Nervetti A; Mela Q; Bianchi G; Del Puente A; Di Munno O; Frediani B; Cantatore F; Pellerito R; Bartolone S; La Montagna G; Adami S
    J Rheumatol; 2000 Nov; 27(11):2582-9. PubMed ID: 11093437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis and fracture risk in women of different ethnic groups.
    Barrett-Connor E; Siris ES; Wehren LE; Miller PD; Abbott TA; Berger ML; Santora AC; Sherwood LM
    J Bone Miner Res; 2005 Feb; 20(2):185-94. PubMed ID: 15647811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
    Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
    Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.